Genomics Market Size, Share, and Outlook, H2-2025 Report- By Products and Services (Consumables and Reagents, Services, Instruments, Systems, Software), By Technology (Sequencing, PCR, Flow Cytometry, Microarrays, Others), By Application (Drug Discovery a
Description
Genomics Market Outlook
The global Genomics Market Size is valued at $41.4 Billion in 2025 and is forecast to reach $98.6 Billion in 2032 at a CAGR of 13.2%.
The Genomics Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Genomics Market segments across 22 countries from 2021 to 2032. Key segments covered include By Products and Services (Consumables and Reagents, Services, Instruments, Systems, Software), By Technology (Sequencing, PCR, Flow Cytometry, Microarrays, Others), By Application (Drug Discovery and Development, Diagnostics, Agriculture and Animal research, Others), By Study Type (Functional Genomics, Biomarker Discovery, Pathway Analysis, Epigenomics, Others), By End-User (Hospitals and Clinics, Academic and Research Institutes, Pharmaceutical & Biotechnology companies, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Genomics Market Insights, 2025
In 2025, the genomics market is being propelled by the convergence of next-generation sequencing, artificial intelligence, and cloud computing, enabling unprecedented insights into human biology. Large-scale initiatives, such as national genome projects and biobanks, are generating vast datasets that fuel research into disease mechanisms and therapeutic targets. Clinical adoption is accelerating as genomics becomes integral to oncology, reproductive health, infectious disease management, and rare disorder diagnosis. AI-powered analytics are transforming raw sequence data into clinically actionable information in a fraction of the time once required. The rise of multi-omics approaches, combining genomics with transcriptomics, proteomics, and metabolomics, is advancing precision medicine to new levels. Cost declines in sequencing continue to break down barriers to accessibility, expanding use in both developed and emerging healthcare systems. Pharmaceutical companies are leveraging genomics for drug discovery, biomarker development, and patient stratification in clinical trials. Data privacy and ethical governance are increasingly important as genomic datasets grow in size and sensitivity. Overall, genomics in 2025 is not just a research tool—it is a central pillar of modern healthcare and therapeutic innovation.
Five Trends Shaping the Global Genomics Market in 2025 and Beyond
The global Genomics Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Genomics Industry?
The Genomics Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Genomics Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Genomics Market Segment Insights
The Genomics Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Products and Services (Consumables and Reagents, Services, Instruments, Systems, Software), By Technology (Sequencing, PCR, Flow Cytometry, Microarrays, Others), By Application (Drug Discovery and Development, Diagnostics, Agriculture and Animal research, Others), By Study Type (Functional Genomics, Biomarker Discovery, Pathway Analysis, Epigenomics, Others), By End-User (Hospitals and Clinics, Academic and Research Institutes, Pharmaceutical & Biotechnology companies, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Genomics Industry Value Chain
The chapter identifies potential companies and their operations across the global Genomics Industry ecosystem. It assists decision-makers in evaluating global Genomics Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Genomics Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Genomics Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Genomics Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Genomics Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Genomics Market.
Europe Genomics Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Genomics Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Genomics Industry competitiveness. The report analyses the key Genomics Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Genomics Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Genomics Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Genomics Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Genomics Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Genomics Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Genomics Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes 10x Genomics Inc, 23andMe Inc, Abbott Laboratories, Agilent Technologies Inc, Becton, Dickinson and Company, BGI Group, Bio-Rad Laboratories Inc, Creative Biogene, Danaher Corp, Eppendorf AG , Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Freenome Holdings Inc, Illumina Inc, Merck KGaA, New England Biolabs Inc, Novogene Co. Ltd, Oxford Nanopore Technologies Ltd, Pacific Biosciences of California Inc, PerkinElmer Inc, Promega Corp, QIAGEN N.V., Takara Bio Inc, Thermo Fisher Scientific Inc, Ultima Genomics Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Genomics Market Scope
Leading Segments
By Products and Services
Consumables and Reagents
Services
Instruments
Systems
Software
By Technology
Sequencing
PCR
Flow Cytometry
Microarrays
Others
By Application
Drug Discovery and Development
Diagnostics
Agriculture and Animal research
Others
By Study Type
Functional Genomics
Biomarker Discovery
Pathway Analysis
Epigenomics
Others
By End-User
Hospitals and Clinics
Academic and Research Institutes
Pharmaceutical & Biotechnology companies
Others
Leading Companies
10x Genomics Inc
23andMe Inc
Abbott Laboratories
Agilent Technologies Inc
Becton, Dickinson and Company
BGI Group
Bio-Rad Laboratories Inc
Creative Biogene
Danaher Corp
Eppendorf AG
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd
Freenome Holdings Inc
Illumina Inc
Merck KGaA
New England Biolabs Inc
Novogene Co. Ltd
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
PerkinElmer Inc
Promega Corp
QIAGEN N.V.
Takara Bio Inc
Thermo Fisher Scientific Inc
Ultima Genomics Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Genomics Market Size is valued at $41.4 Billion in 2025 and is forecast to reach $98.6 Billion in 2032 at a CAGR of 13.2%.
The Genomics Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Genomics Market segments across 22 countries from 2021 to 2032. Key segments covered include By Products and Services (Consumables and Reagents, Services, Instruments, Systems, Software), By Technology (Sequencing, PCR, Flow Cytometry, Microarrays, Others), By Application (Drug Discovery and Development, Diagnostics, Agriculture and Animal research, Others), By Study Type (Functional Genomics, Biomarker Discovery, Pathway Analysis, Epigenomics, Others), By End-User (Hospitals and Clinics, Academic and Research Institutes, Pharmaceutical & Biotechnology companies, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Genomics Market Insights, 2025
In 2025, the genomics market is being propelled by the convergence of next-generation sequencing, artificial intelligence, and cloud computing, enabling unprecedented insights into human biology. Large-scale initiatives, such as national genome projects and biobanks, are generating vast datasets that fuel research into disease mechanisms and therapeutic targets. Clinical adoption is accelerating as genomics becomes integral to oncology, reproductive health, infectious disease management, and rare disorder diagnosis. AI-powered analytics are transforming raw sequence data into clinically actionable information in a fraction of the time once required. The rise of multi-omics approaches, combining genomics with transcriptomics, proteomics, and metabolomics, is advancing precision medicine to new levels. Cost declines in sequencing continue to break down barriers to accessibility, expanding use in both developed and emerging healthcare systems. Pharmaceutical companies are leveraging genomics for drug discovery, biomarker development, and patient stratification in clinical trials. Data privacy and ethical governance are increasingly important as genomic datasets grow in size and sensitivity. Overall, genomics in 2025 is not just a research tool—it is a central pillar of modern healthcare and therapeutic innovation.
Five Trends Shaping the Global Genomics Market in 2025 and Beyond
The global Genomics Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Genomics Industry?
The Genomics Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Genomics Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Genomics Market Segment Insights
The Genomics Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Products and Services (Consumables and Reagents, Services, Instruments, Systems, Software), By Technology (Sequencing, PCR, Flow Cytometry, Microarrays, Others), By Application (Drug Discovery and Development, Diagnostics, Agriculture and Animal research, Others), By Study Type (Functional Genomics, Biomarker Discovery, Pathway Analysis, Epigenomics, Others), By End-User (Hospitals and Clinics, Academic and Research Institutes, Pharmaceutical & Biotechnology companies, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Genomics Industry Value Chain
The chapter identifies potential companies and their operations across the global Genomics Industry ecosystem. It assists decision-makers in evaluating global Genomics Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Genomics Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Genomics Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Genomics Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Genomics Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Genomics Market.
Europe Genomics Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Genomics Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Genomics Industry competitiveness. The report analyses the key Genomics Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Genomics Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Genomics Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Genomics Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Genomics Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Genomics Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Genomics Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes 10x Genomics Inc, 23andMe Inc, Abbott Laboratories, Agilent Technologies Inc, Becton, Dickinson and Company, BGI Group, Bio-Rad Laboratories Inc, Creative Biogene, Danaher Corp, Eppendorf AG , Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Freenome Holdings Inc, Illumina Inc, Merck KGaA, New England Biolabs Inc, Novogene Co. Ltd, Oxford Nanopore Technologies Ltd, Pacific Biosciences of California Inc, PerkinElmer Inc, Promega Corp, QIAGEN N.V., Takara Bio Inc, Thermo Fisher Scientific Inc, Ultima Genomics Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Genomics Market Scope
Leading Segments
By Products and Services
Consumables and Reagents
Services
Instruments
Systems
Software
By Technology
Sequencing
PCR
Flow Cytometry
Microarrays
Others
By Application
Drug Discovery and Development
Diagnostics
Agriculture and Animal research
Others
By Study Type
Functional Genomics
Biomarker Discovery
Pathway Analysis
Epigenomics
Others
By End-User
Hospitals and Clinics
Academic and Research Institutes
Pharmaceutical & Biotechnology companies
Others
Leading Companies
10x Genomics Inc
23andMe Inc
Abbott Laboratories
Agilent Technologies Inc
Becton, Dickinson and Company
BGI Group
Bio-Rad Laboratories Inc
Creative Biogene
Danaher Corp
Eppendorf AG
Eurofins Scientific SE
F. Hoffmann-La Roche Ltd
Freenome Holdings Inc
Illumina Inc
Merck KGaA
New England Biolabs Inc
Novogene Co. Ltd
Oxford Nanopore Technologies Ltd
Pacific Biosciences of California Inc
PerkinElmer Inc
Promega Corp
QIAGEN N.V.
Takara Bio Inc
Thermo Fisher Scientific Inc
Ultima Genomics Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
180 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Genomics Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Genomics Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Genomics Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Genomics Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Genomics Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Products and Services
- Consumables and Reagents
- Services
- Instruments
- Systems
- Software
- By Technology
- Sequencing
- PCR
- Flow Cytometry
- Microarrays
- Others
- By Application
- Drug Discovery and Development
- Diagnostics
- Agriculture and Animal research
- Others
- By Study Type
- Functional Genomics
- Biomarker Discovery
- Pathway Analysis
- Epigenomics
- Others
- By End-User
- Hospitals and Clinics
- Academic and Research Institutes
- Pharmaceutical & Biotechnology companies
- Others
- 6. Global Genomics Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Genomics Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Genomics Market Trends and Growth Opportunities
- 6.2.1 North America Genomics Market Outlook by Type
- 6.2.2 North America Genomics Market Outlook by Application
- 6.3 North America Genomics Market Outlook by Country
- 6.3.1 The US Genomics Market Outlook, 2021- 2032
- 6.3.2 Canada Genomics Market Outlook, 2021- 2032
- 6.3.3 Mexico Genomics Market Outlook, 2021- 2032
- 7. Europe Genomics Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Genomics Market Trends and Growth Opportunities
- 7.2.1 Europe Genomics Market Outlook by Type
- 7.2.2 Europe Genomics Market Outlook by Application
- 7.3 Europe Genomics Market Outlook by Country
- 7.3.2 Germany Genomics Market Outlook, 2021- 2032
- 7.3.3 France Genomics Market Outlook, 2021- 2032
- 7.3.4 The UK Genomics Market Outlook, 2021- 2032
- 7.3.5 Spain Genomics Market Outlook, 2021- 2032
- 7.3.6 Italy Genomics Market Outlook, 2021- 2032
- 7.3.7 Russia Genomics Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Genomics Market Outlook, 2021- 2032
- 8. Asia Pacific Genomics Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Genomics Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Genomics Market Outlook by Type
- 8.2.2 Asia Pacific Genomics Market Outlook by Application
- 8.3 Asia Pacific Genomics Market Outlook by Country
- 8.3.1 China Genomics Market Outlook, 2021- 2032
- 8.3.2 India Genomics Market Outlook, 2021- 2032
- 8.3.3 Japan Genomics Market Outlook, 2021- 2032
- 8.3.4 South Korea Genomics Market Outlook, 2021- 2032
- 8.3.5 Australia Genomics Market Outlook, 2021- 2032
- 8.3.6 South East Asia Genomics Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Genomics Market Outlook, 2021- 2032
- 9. South America Genomics Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Genomics Market Trends and Growth Opportunities
- 9.2.1 South America Genomics Market Outlook by Type
- 9.2.2 South America Genomics Market Outlook by Application
- 9.3 South America Genomics Market Outlook by Country
- 9.3.1 Brazil Genomics Market Outlook, 2021- 2032
- 9.3.2 Argentina Genomics Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Genomics Market Outlook, 2021- 2032
- 10. Middle East and Africa Genomics Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Genomics Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Genomics Market Outlook by Type
- 10.2.2 Middle East and Africa Genomics Market Outlook by Application
- 10.3 Middle East and Africa Genomics Market Outlook by Country
- 10.3.1 Saudi Arabia Genomics Market Outlook, 2021- 2032
- 10.3.2 The UAE Genomics Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Genomics Market Outlook, 2021- 2032
- 10.3.4 South Africa Genomics Market Outlook, 2021- 2032
- 10.3.5 Egypt Genomics Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Genomics Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- 10x Genomics Inc
- 23andMe Inc
- Abbott Laboratories
- Agilent Technologies Inc
- Becton, Dickinson and Company
- BGI Group
- Bio-Rad Laboratories Inc
- Creative Biogene
- Danaher Corp
- Eppendorf AG
- Eurofins Scientific SE
- F. Hoffmann-La Roche Ltd
- Freenome Holdings Inc
- Illumina Inc
- Merck KGaA
- New England Biolabs Inc
- Novogene Co. Ltd
- Oxford Nanopore Technologies Ltd
- Pacific Biosciences of California Inc
- PerkinElmer Inc
- Promega Corp
- QIAGEN N.V.
- Takara Bio Inc
- Thermo Fisher Scientific Inc
- Ultima Genomics Inc
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
